Items where Author is "Miracolo, Aurelio"

Number of items: 9.
  • Launch sequencing of pharmaceuticals with multiple therapeutic indications:evidence from seven countries. (2023) Mills, Mackenzie; Michaeli, Daniel; Miracolo, Aurelio; Kanavos, Panos picture_as_pdf
  • Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. (2022) Michaeli, Daniel Tobias; Mills, Mackenzie; Michaeli, Thomas; Miracolo, Aurelio; Kanavos, Panos picture_as_pdf
  • Access to personalised oncology in Europe. Gill, Jennifer; Fontrier, Anna-Maria; Miracolo, Aurelio; Kanavos, Panos
  • HPR85 Opinions on sustainable healthcare financing options for funding new medical technologies in Asean-6. Gill, Jennifer L; Chávez, Danitza; Main, Caitlin; Miracolo, Aurelio; Kanavos, Panos
  • How can we improve secondary prevention of cardiovascular disease? Gill, Jennifer; Miracolo, Aurelio; Politopoulou, Konstantina; Jayawardana, Sahan; Carter, Alex; Apostolou, Efstratios A.; Kanavos, Panos picture_as_pdf
  • MSR1 Estimating lifetime benefits of optimizing secondary preventive treatment for atherosclerotic cardiovascular disease. Gill, Jennifer L; Miracolo, Aurelio; Politopoulou, Konstantina; Jayawardana, Sahan; Apostolou, Efstratios A.; Carter, Alex; Kanavos, Panos
  • Sin taxes and their effect on consumption, revenue generation and health improvement:a systematic literature review in Latin America. Miracolo, Aurelio; Sophiea, Marisa; Mills, Mackenzie; Kanavos, Panos picture_as_pdf
  • Sustainable healthcare financing for SDG3 in ASEAN-6. Gill, Jennifer; Chávez, Danitza; Main, Caitlin; Miracolo, Aurelio; Fontrier, Anna-Maria; Kanavos, Panos picture_as_pdf
  • The burden of diabetes and options for reform:insights for the Greek health system. Haig, Madeleine; Therianos, Panagiotis; Miracolo, Aurelio; Satish, Kavyashree; Kolovou, Vasiliki; Kanavos, Panos picture_as_pdf